|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/5575 | (2006.01) |
| A61K 31/5575 | (2013.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61P 25/06 | (2018.01) | ||
| A61P 25/06 | (2006.01) |
| (11) | Patento numeris | 3091985 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15735190.9 |
| Europos patento paraiškos padavimo data | 2015-01-09 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-11-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-05-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/010771 |
| Data | 2015-01-09 |
| (87) | Numeris | WO 2015/106068 |
| Data | 2015-07-16 |
| (30) | Numeris | Data | Šalis |
| 201461925676 P | 2014-01-10 | US |
| (72) |
BRATZLER, Robert, L. , US
WAND, Martin , US
RYCKMAN, Frederick , US
SHINGLETON, Bradford, J. , US
|
| (73) |
Manistee Therapeutics, Inc. ,
84 Barnes Hill Road, Concord, MA 01742-5601,
US
|
| (54) | PROSTANGLANDINS FOR TOPICAL USE IN THE TREATMENT OF MIGRAINES. |
| PROSTANGLANDINS FOR TOPICAL USE IN THE TREATMENT OF MIGRAINES. |